Journal Mobile Options
Table of Contents
Vol. 82, No. 1, 2005
Issue release date: 2005
Neuroendocrinology 2005;82:49–57

Induction of Fos Immunoreactivity Labeling in Rat Forebrain Metabolic Loci by Caudal Fourth Ventricular Infusion of the Monocarboxylate Transporter Inhibitor, Alpha-Cyano-4-Hydroxycinnamic Acid

Briski K.P. · Patil G.D.
Department of Basic Pharmaceutical Sciences, School of Pharmacy, College of Health Sciences, University of Louisiana at Monroe, Monroe, La., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Caudal fourth ventricular (CV4) infusion of the monocarboxylate transporter inhibitor, α-cyano-4-hydroxycinnamic acid (4CIN), causes hyperglycemia coincident with Fos expression in the hindbrain nucleus tractus solitarius, a rare central source of metabolic deficit signaling. The present studies examined the hypothesis that hindbrain lactoprivic signaling activates central autonomic pathways that regulate systemic glucostasis by examining the effects of this drug treatment paradigm on patterns of Fos expression in forebrain structures that integrate sensory input from metabolic sensors and coordinate motor responses to energy shortages. Two hours after CV4 infusion of graded doses of 4CIN or vehicle alone, adult female rats were sacrificed by transcardial perfusion and sections through the telencephalic and diencephalic metabolic loci were processed for Fos immunoreactivity (-ir). Fos labeling of the hypothalamic paraventricular (PVH), dorsomedial (DMH), and ventromedial (VMH) nuclei was significantly elevated, relative to the vehicle-treated controls, in response to the lowest dose of 4CIN, e.g. 10 µg/animal. Treatment with higher doses of 4CIN (25 or 50 µg) further augmented numbers of Fos-ir-positive neurons in these structures, and also elicited staining of the bed nuclei of the stria terminalis (BST), medial preoptic (MPN), arcuate (ARH), supraoptic (SO), and anterior hypothalamic nuclei (AHN), and lateral hypothalamic area (LHA). Mean numbers of Fos-immunolabeled neurons in the ARH, DMH, LHA, AHN, MPN, and SO were not different between animals infused with 25 versus 50 µg 4CIN, whereas neuronal labeling in the VMH, BST, and PVH was significantly greater in the high- versus the middle-dose groups. The present data show that pharmacological inhibition of lactate uptake within the caudal hindbrain results in dose-dependent neuronal Fos immunoexpression within characterized forebrain components of the central metabolic circuitry, and that these patterns of neuronal transcriptional activation parallel observed drug effects on blood glucose levels. These results suggest that lactoprivic signaling by metabolic ‘sensing’ neurons in the caudal hindbrain initiates central neural mechanisms that control systemic energy availability, and that local lactate-‘sensitive’ neurons are connected neuroanatomically with principal higher-order autonomic metabolic loci that regulate glucostasis.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Oomura Y, Ono T, Ooyama H, Wayner MJ: Glucose and osmosensitive neurones of the rat hypothalamus. Nature 1969:222:282–284.
  2. Oomura Y, Yoshimatsu H: Neural network of glucose monitoring system. J Auton Nerv Syst 1984;10:359–372.
  3. Nijima A: Nervous regulation of metabolism. Prog Neurobiol 1988;33:135–147.
  4. Ritter RC, Slusser PC, Stone S: Glucoreceptors controlling feeding and blood glucose are in the hindbrain. Science 1981;213:451–452.
  5. Flynn FW, Grill HJ: Fourth ventricular phlorizin dissociates feeding from hyperglycemia in rats. Brain Res 1985;341:331–336.
  6. Ames A: CNS energy metabolism as related to function. Brain Res Rev 2000;34:42–68.
  7. Vannucci SJ, Maher F, Simpson IA: Glucose transporter proteins in brain: delivery of glucose to neurons and glia. Glia1997;21:2–21.
  8. Laming PR, Kimelberg H, Robinson S: Neuronal-glial interactions and behavior. Neurosci Biobehav Rev 2000;24:295–340.
  9. Pellerin L, Halestrap AP, Pierre K: Cellular and subcellular distribution of monocarboxylate transporters in cultured brain cells in the adult brain. J Neurosci Res 2005;79:55–64.
  10. Himmi T, Perrin J, Dallaporta M, Orsini JC: Effects of lactate on glucose-sensing neurons in the solitary tract nucleus. Physiol Behav 2001;74:391–397.
  11. Patil GD, Briski KP: Lactate is a critical ‘sensed’ variable in caudal hindbrain monitoring of CNS metabolic stasis. Am J Physiol Regul Integr Comp Physiol 2005; doi:10.1152/ajpregu.00177.2004.
  12. Patil GD, Briski KP: Transcriptional activation of nucleus tractus solitarius/area postrema catecholaminergic neurons by pharmacological inhibition of caudal hindbrain monocarboxylate transporter function. Neuroendocrinology 2005;81:96–102.
  13. Adachi A, Kobashi M, Miyoshi N, Tsukamoto G: Chemosensitive neurons in the area postrema of the rat. Brain Res Bull 1991;26:137–140.
  14. Adachi A, Kobashi M, Funahashi M: Glucose-responsive neurons in the brainstem. Obes Res 1995;3(suppl 5):735S–740S.
  15. Yettefti K, Orsini JC, el Ouazzani T, Himmi T, Boyer A, Perrin J: Sensitivity of nucleus tractus solitarius neurons to induced moderate hyperglycemia, with special reference to catecholaminergic regions. J Auton Nerv Syst 1995;51:191–197.
  16. Briski KP: Hindbrain glucoprivic inhibition of the proestrus luteinizing hormone surge in the female rat is attenuated by exogenous lactate administration. Neurosci Res Commum 2002;31:67–73.
  17. Loewy AD: Central autonomic pathways; in Loewy AD, Spyer KM (eds): Central Regulation of Autonomic Functions. New York, Oxford University Press, 1990, pp 88–103.
  18. Broer S, Broer A, Schneider HP, Stegen CF, Halestrap AP, Deitmer JW: Characterization of the high-affinity monocarboxylate transporter MCT2 in Xenopus laevis oocytes. Biochem J 1999;341:529–535.
  19. Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, Kalra PS: Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 1999;20:68–100.
  20. Evans SB, Wilkinson SW, Bentson K, Gronbeck P, Zavosh A, Figlewicz DP: PVN activation is suppressed by repeated hypoglycemia but not antecedent corticosterone in the rat. Am J Physiol Regul Integr Comp Physiol 2001;281:R1426–R1436.
  21. Niimi M, Sato M, Tamaki M, Wada Y, Takahara J, Kawanishi K: Induction of Fos protein in the rat hypothalamus elicited by insulin-induced hypoglycemia. Neurosci Res 1995;19:361–364.
  22. Paranjape SA, Briski KP: Recurrent insulin-induced hypoglycemia causes site-specific patterns of habituation or amplification of CNS neuronal genomic activation. Neuroscience 2005;130:957–970.
  23. Briski KP, Sylvester PW: Site-specific induction of Fos-immunoreactivity in preoptic and hypothalamic NADPH-positive neurons during glucoprivation. Neuroendocrinology 1999;69:181–190.
  24. Ritter S, Dinh TT: 2-Mercaptoacetate and 2-deoxy-D-glucose induce Fos-like immunoreactivity in rat brain. Brain Res 1994;641:111–120.
  25. Borg A, Tamborlane WV, Shulman GI, Sherwin RS: Local lactate perfusion of the ventromedial hypothalamus suppresses hypoglycemia counterregulation. Diabetes 2003;52:663–666.
  26. Yang XJ, Kow LM, Funabashi T, Mobbs CV: Hypothalamic glucose sensor: similarities to and differences from pancreatic β-cell mechanisms. Diabetes2004;48:1763–1772.
  27. Yang XJ, Kow LM, Pfaff DW, Mobbs CV: Metabolic pathways that mediate inhibition of hypothalamic neurons by glucose. Diabetes 2004;53:67–73.
  28. Leino RL, Gerhart DZ, Drewes LR: Monocarboxylate transporter (MCT1) abundance in brains of suckling and adult rats: a quantitative electron microscopic immunogold study. Brain Res Dev Brain Res 1999;113:47–54.
  29. Tseng MT, Chan SA, Schurr A: Ischemia-induced changes in monocarboxylate transporter 1 reactive-cells in rat hippocampus. Neurol Res 2003;25:83–86.
  30. Gerhart DZ, Enerson BE, Zhdankina OY, Leino RL, Drewes LR: Expression of the monocarboxylate transporter MCT2 by rat brain glia. Glia 1998;22:272–281.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50